Xfund

Patrick Chung, Xfund's co-founder and managing partner, leads the investment team and chairs the investment committee. Chung previously spent over a decade at NEA, where he invested in consumer and enterprise technology companies. David Fialkow, co-founder of General Catalyst, serves as the other managing partner, bringing deep venture-building expertise to portfolio-company development.

Xfund sources deals through formal partnerships with Harvard, Stanford, MIT, and the University of Cambridge, embedding investors within research labs to identify commercially viable IP before it enters formal venture pipelines. The firm's venture partners include tenured faculty members and lab directors who surface technically defensible opportunities at the formation stage. This university-centric model gives Xfund a window into faculty-founded startups and PhD-led ventures months ahead of traditional seed investors.

Xfund is an independent venture capital firm that functions as a hybrid between a traditional early-stage fund and a university-linked technology-transfer partner. Unlike internal university venture offices, Xfund invests third-party LP capital and takes active board roles in portfolio companies. Its formal partnerships with universities grant it preferential deal access without limiting its investment mandate to partner-institution spinouts alone.

Xfund focuses on seed-stage and early-stage startups, often writing the first institutional check into companies emerging from academic research environments. The firm leads or co-leads rounds designed to carry companies toward Series A, with a portfolio that spans pre-revenue ventures through early-commercialization businesses. Xfund occasionally participates in follow-on rounds for top-performing portfolio companies.

Xfund concentrates on enterprise software, artificial intelligence and machine learning, digital health, fintech, and consumer technology — areas where university research produces directly commercializable IP. The firm generally avoids capital-intensive industries like hard manufacturing, energy infrastructure, and therapeutics development that require clinical trials and regulatory approval, preferring sectors where software and data-science advantages can compound quickly.

Xfund invests exclusively through direct deals and co-investments alongside other venture firms rather than making fund-of-funds commitments. The firm's model relies on leading or co-leading early-stage rounds and building concentrated positions in its portfolio companies. This direct-investment approach aligns with Xfund's high-touch involvement in company formation.

David Fialkow, Xfund's co-founder, is a co-founder and managing director of General Catalyst, one of the largest technology-focused venture capital firms. Patrick Chung, Xfund's other co-founder, was formerly a partner at NEA. While Xfund maintains close ties to both firms — frequently co-investing alongside them — it operates as an entirely independent fund with its own limited partners, investment committee, and portfolio construction.